Pure Global

Remote Home Assessment of Patients With Amyotrophic Lateral Sclerosis - Trial NCT06046599

Access comprehensive clinical trial information for NCT06046599 through Pure Global AI's free database. This phase not specified trial is sponsored by King's College London and is currently Recruiting. The study focuses on Amyotrophic Lateral Sclerosis. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06046599
Recruiting
Trial Details
ClinicalTrials.gov โ€ข NCT06046599
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Remote Home Assessment of Patients With Amyotrophic Lateral Sclerosis

Study Focus

Observational

Sponsor & Location

King's College London

London, United Kingdom

Timeline & Enrollment

N/A

Oct 24, 2022

Feb 01, 2024

20 participants

Primary Outcome

EMG activity

Summary

The goal of this observational study is the develop new ways of remotely monitoring the
 health and symptoms of people living with amyotrophic lateral sclerosis from within their
 homes. The main questions it aims to answer are:
 
 - Can we integrate a new muscle monitoring device into Imperial College London's home
 monitoring platform?
 
 - Can we investigate and understand the relationship between muscle activity and measure
 of patient behaviour (e.g., patient movement), physiology (e.g., pulse/blood pressure
 variation) and sleep quality from the home?
 
 - Can we establish a home-based multimodal biomarker that tracks the neurodegenerative
 process in ALS? Participants will have passive internet-of-things sensors and
 internet-enabled medical devices installed in their homes for one year. Some sensors
 will record automatically without any interaction from the participants, but some will
 require participants to engage with daily (e.g., blood pressure monitor) on their own or
 with the help of a study partner.
 
 Where possible, researchers will compare the collected data to other neurodegenerative
 diseases and healthy controls to understand differences over time.

ICD-10 Classifications

Neuralgic amyotrophy
Motor neuron disease
Other degenerative diseases of the nervous system
Other degenerative disorders of nervous system in diseases classified elsewhere
Multiple sclerosis

Data Source

ClinicalTrials.gov

NCT06046599

Non-Device Trial